Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : Kirk's Market Thoughts -- Ignore unavailable to you. Want to Upgrade?

To: Kirk © who wrote (9064)	4/6/2020 9:43:25 PM
From: Kirk ©	Read Replies (2) \| Respond to of 26642

Fujifilm, Camera and Film Giant, Is Leading Japan’s Fight to Cure Coronavirus A subsidiary of the Japanese photography and imaging company is behind an antiviral pill being used to treat COVID-19 in Japan and Turkey. Zack Sharf Apr 6, 2020 11:30 am Beginning March 28, Japan’s prime minster Shinzo Abe “designated Avigan as Japan’s standard treatment for COVID-19.” According to Wired’s report, “At a hospital in Shenzhen, COVID-19 patients treated with Favipiravir tested negative for the virus after a median of four days, rather than the 11 days it took for members of the study’s control group to test negative; in another study carried out in Wuhan, patients taking the drug allegedly recovered from fever nearly two days earlier than those who did not take the medication.” Japan is now relying on Favipiravir to help fight COVID-19, as are countries such as Turkey. The antiviral pill works “by inhibiting the replication of viral genes within infected cells, thereby mitigating the virus’ ability to spread from one cell to another.” The Fujifilm team is in the middle of a clinical trial using the antiviral pill that will conclude in June. The hope is that the drug will prevent COVID-19 patients with low viral loads from getting any sicker. Japan’s prime minster announced last weekend the country will “start to boost production and proceed with clinical research in cooperation with those countries that wish to join us.” Unlike the majority of the world, Japan hasn’t seen an explosion in COVID-19 cases and deaths. As of April 3, there have been 2,617 reported cases of the disease in the country and only 61 deaths. Fujimfilm team members told Wired that Indonesia is one of several counties contacting them and expressing interest in using Favipiravir to fight COVID-19, but the company “declined to name them [all the countries] and won’t say how much of the drug they will be exporting.” indiewire.com